Who can advise you if you are concerned about an adverse reaction to a medication?
|
1. Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S. Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005. Jun;9(3):381-390 10.1111/j.1399-3046.2005.00356.x [PubMed] [CrossRef] [Google Scholar] Show 2. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006. Jul;130(1)(Suppl):65S-72S 10.1378/chest.130.1_suppl.65S [PubMed] [CrossRef] [Google Scholar] 3. Agras WS. Understanding compliance with the medical regimen: the scope of the problem and a theoretical perspective. Arthritis Care Res 1989. Sep;2(3):S2-S7 10.1002/anr.1790020308 [PubMed] [CrossRef] [Google Scholar] 4. Noble LM. Doctor–patient communication and adherence to treatment. In: Myers LB, Midence K, eds. Adherence to treatment in medical conditions. Harwood Academic Publishers, 1998.p.51–82. [Google Scholar] 5. Carr AJ, Donovan JL. Why doctors and patients disagree. Br J Rheumatol 1998. Jan;37(1):1-4 10.1093/rheumatology/37.1.1a [PubMed] [CrossRef] [Google Scholar] 6. Spiro H. Compliance, adherence, and hope. J Clin Gastroenterol 2001. Jan;32(1):5 10.1097/00004836-200101000-00003 [PubMed] [CrossRef] [Google Scholar] 7. Di Matteo MR. Adherence to treatment. In: Feldman MD, Christensen JF, eds. Behavioral medicine in primary care. A practical guide. Stamford, Connecticut: Appleton and Lange, 1997.p.136–140. [Google Scholar] 8. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998. Aug;36(8):1138-1161 10.1097/00005650-199808000-00004 [PubMed] [CrossRef] [Google Scholar] 10. Horne R, Weinman J, Barber N, Elliott RA, Morgan M. Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities. London, National Co-ordinating Centre for NHS Service Delivery and Organisation NCCSDO; 2005. [Google Scholar] 11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005. Aug;353(5):487-497 10.1056/NEJMra050100 [PubMed] [CrossRef] [Google Scholar] 12. Grahame-Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 3rd Edition. Oxford University Press, USA. 2002. [Google Scholar] 15. Ley P. Communicating with patients: improving communication, satisfaction and compliance. Cheltenham, Stanley Thornes Pub Ltd. 1997. [Google Scholar] 16. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002. Jul;288(4):462-467 10.1001/jama.288.4.462 [PubMed] [CrossRef] [Google Scholar] 17. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J, VA Naltrexone Study Group 425 Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003. Sep-Oct;6(5):566-573 10.1046/j.1524-4733.2003.65269.x [PubMed] [CrossRef] [Google Scholar] 18. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002. Dec;288(22):2880-2883 10.1001/jama.288.22.2880 [PubMed] [CrossRef] [Google Scholar] 19. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990. Apr;150(4):841-845 10.1001/archinte.150.4.841 [PubMed] [CrossRef] [Google Scholar] 20. Sullivan S, Kreling D, Hazlet T. Noncompliance with medication regimens and subsequent hospitalizations: A literature analysis and cost of hospitalization estimate. J Res Pharmaceut Econ 1990;2:19-33 [Google Scholar] 21. Anon.Poor medication adherence increases healthcare costs. PharmacoEconomics and Outcomes News. 2005;480:5 [Google Scholar] 22. Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995. Mar;98(3):272-277 10.1016/S0002-9343(99)80374-X [PubMed] [CrossRef] [Google Scholar] 23. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Antó JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 2000. Dec;16(6):1037-1042 10.1034/j.1399-3003.2000.16f03.x [PubMed] [CrossRef] [Google Scholar] 24. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005. Jun;43(6):521-530 10.1097/01.mlr.0000163641.86870.af [PubMed] [CrossRef] [Google Scholar] 26. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996. Aug;348(9024):383-386 10.1016/S0140-6736(96)01073-2 [PubMed] [CrossRef] [Google Scholar] 27. Haynes RB, Devereaux PJ, Guyatt GH. Physicians’ and patients’ choices in evidence based practice. BMJ 2002. Jun;324(7350):1350 10.1136/bmj.324.7350.1350 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 28. Cox K, Stevenson F, Britten N, Dundar Y. A Systematic Review of Communication between Patients and Health Providers about Medicine-taking and Prescribing. GKT Concordance Unit, Kings College, 2003. [Google Scholar] 29. Leupkar RV. Patient adherence: A "risk factor" for cardiovascular disease. The Framington Study. JAMA 1971;215:1617-1625 [PubMed] [Google Scholar] 30. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med 2006. Sep;166(17):1855-1862 10.1001/archinte.166.17.1855 [PubMed] [CrossRef] [Google Scholar] 31. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 2006. Apr;144(7):475-484 [PMC free article] [PubMed] [Google Scholar] 32. Sewitch MJ, Dobkin PL, Bernatsky S, Baron M, Starr M, Cohen M, et al. Medication non-adherence in women with fibromyalgia. Rheumatology (Oxford) 2004. May;43(5):648-654 10.1093/rheumatology/keh241 [PubMed] [CrossRef] [Google Scholar] 33. Sackett DL, Snow JC. The magnitude of compliance and non compliance. IN Haynes NRB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: John Hopkins University Press; 1979:11-22. [Google Scholar] 34. Dunbar J. Issues in assessment. In: Cohen NSJ. ed. New directions in Patient Compliance. New York: Lexington Books, 1979.p.41-57. [Google Scholar] 35. Haynes RB, Taylor DW, Snow JC, Sackett DL. Annotated and indexed bibliography on compliance with therapeutic and preventive regimens. In: Haynes RB, Taylor DC, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.p.337–474. [Google Scholar] 36. Francis V, Korsch BM, Morris MJ. Gaps in doctor-patient communication. Patients’ response to medical advice. N Engl J Med 1969. Mar;280(10):535-540 10.1056/NEJM196903062801004 [PubMed] [CrossRef] [Google Scholar] 37. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med 1992. Oct;15(5):447-468 10.1007/BF00844941 [PubMed] [CrossRef] [Google Scholar] 38. Würtemberger G, Hütter BO. Health-related quality of life, psychological adjustment and compliance to treatment in patients on domiciliary liquid oxygen. Monaldi Arch Chest Dis 2000. Jun;55(3):216-224 [PubMed] [Google Scholar] 39. Oermann CM, Swank PR, Sockrider MM. Validation of an instrument measuring patient satisfaction with chest physiotherapy techniques in cystic fibrosis. Chest 2000. Jul;118(1):92-97 10.1378/chest.118.1.92 [PubMed] [CrossRef] [Google Scholar] 40. Weingarten SR, Stone E, Green A, Pelter M, Nessim S, Huang H, et al. A study of patient satisfaction and adherence to preventive care practice guidelines. Am J Med 1995. Dec;99(6):590-596 10.1016/S0002-9343(99)80243-5 [PubMed] [CrossRef] [Google Scholar] 41. Svarstad B. Physician-patient communication and patient conformity with medical advice. In: Mechanic D, ed. The Growth of Bureaucratic Medicine. New York: John Wiley & Sons Inc; 1976. [Google Scholar] 42. Ley PN, Spellman MS. Communication with the Patient. London: Staples Press; 1967. [Google Scholar] 43. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner’s Guidebook. New York: Plenum Publishing Corp; 1987. [Google Scholar] 44. Burnier M. Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension. Blood Press Monit 2000;5(Suppl 1):S31-S34 10.1097/00126097-200005001-00006 [PubMed] [CrossRef] [Google Scholar] 45. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997. Oct;20(10):1512-1517 10.2337/diacare.20.10.1512 [PubMed] [CrossRef] [Google Scholar] 46. Praska JL, Kripalani S, Seright AL, Jacobson TA. Identifying and assisting low-literacy patients with medication use: a survey of community pharmacies. Ann Pharmacother 2005. Sep;39(9):1441-1445 10.1345/aph.1G094 [PubMed] [CrossRef] [Google Scholar] 47. Ward A, Morgan W. Adherence patterns of health in men and women enrolled in an adult exercise program. J Cardiac Rehabil. 1984;4:143-152 [Google Scholar] 48. Ley P. Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance. J Hypertens Suppl 1985. Apr;3(1):S51-S55 [PubMed] [Google Scholar] 49. Adisa R, Alutundu MB, Fakeye TO. Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharmacy Practice 2009;7:163-169. internet. [PMC free article] [PubMed] [Google Scholar] 50. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care 1996. Oct;19(10):1153-1164 10.2337/diacare.19.10.1153 [PubMed] [CrossRef] [Google Scholar] 51. Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, Rodriguez-Barradas M, VACS 3 Project Team Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol 2001. Dec;54(Suppl 1):S91-S98 10.1016/S0895-4356(01)00450-4 [PubMed] [CrossRef] [Google Scholar] 52. Alcoba M, Cuevas MJ, Perez-Simon MR, Mostaza JL, Ortega L, Ortiz de Urbina J, et al.HAART Adherence Working Group for the Province of Leon, Spain Assessment of adherence to triple antiretroviral treatment including indinavir: role of the determination of plasma levels of indinavir. J Acquir Immune Defic Syndr 2003. Jun;33(2):253-258 10.1097/00126334-200306010-00022 [PubMed] [CrossRef] [Google Scholar] 53. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002. Jan;16(2):269-277 10.1097/00002030-200201250-00017 [PubMed] [CrossRef] [Google Scholar] 54. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980. Nov-Dec;2(6):757-764 [PubMed] [Google Scholar] 55. Rudd P, Byyny RL, Zachary V, LoVerde ME, Mitchell WD, Titus C, et al. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens 1988. Jul;1(3 Pt 1):309-312 [PubMed] [Google Scholar] 56. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989. Aug;46(2):163-168 10.1038/clpt.1989.121 [PubMed] [CrossRef] [Google Scholar] 57. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989. Jun;261(22):3273-3277 10.1001/jama.261.22.3273 [PubMed] [CrossRef] [Google Scholar] 58. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997. Jan;50(1):105-116 10.1016/S0895-4356(96)00268-5 [PubMed] [CrossRef] [Google Scholar] 59. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997. May;50(5):619-625 10.1016/S0895-4356(97)00040-1 [PubMed] [CrossRef] [Google Scholar] 60. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997. Nov;35(11):1164-1170 10.1097/00005650-199711000-00008 [PubMed] [CrossRef] [Google Scholar] Who should be contacted to report an adverse medication reaction?Reports from health professionals are preferred, in particular from doctors and other prescribers, pharmacists and nurses. Interestingly, 65% of the reports CARM receives are from community doctors (mostly general practitioners) while hospital doctors contribute 17% of the reports.
Who is responsible for reporting an adverse drug reaction?Physicians' professional commitment to advance scientific knowledge and make relevant information available to patients, colleagues, and the public carries with it the responsibility to report suspected adverse events resulting from the use of a drug or medical device.
When should an adverse drug reaction be reported?Serious reactions include those that are fatal, life-threatening, disabling, incapacitating, or which result in or prolong hospitalisation, or a congenital abnormality; they should be reported even if the effect is well recognised.
Who to talk to about medications?Your pharmacist can help you learn how to use your prescription and nonprescription (over-the-counter) medicines safely and effectively. You can also use these tips when talking with your other healthcare providers.
|
